End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.11 CNY | -0.94% | +11.51% | +7.53% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.53% | 6.62B | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- LTZ Therapeutics announced that it has received $17 million in funding from K2VC, Qiming Weichuang Venture Capital Management Company Limited, Hangzhou Tigermed Consulting Co., Ltd